Items Tagged ‘Zetia’

November 18, 2009

AHA: ARBITER 6-HALTS — Are There Any Clinical Implications?

By Kelley Luckstein

By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy…   Stephen Kopecky, MD, a cardiologist at the Mayo Clinic, in Rochester, Minn., said there was no doubt that “surrogate endpoints are being overused. […]

View full entry

Tags: AHA, Niaspan, Zetia


November 17, 2009

Doctors gird for patient anxiety over Zetia data

By Kelley Luckstein

The good news for Merck & Co’s Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is they think patient anxiety will cause its sales to drop anyway…   Dr. Stephen Kopecky, professor of medicine and cardiovascular disease at the prestigious Mayo […]

View full entry

Tags: cholesterol, Zetia


Contact Us · Privacy Policy